Cesare Gridelli, M.D.
San Giuseppe Moscati Hospital, Avellino, Italy
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Worked with same sponsors:
Ciro Gallo, M.D., Ph.D
Second University of Naples, Italy; Chair of Medical Statistics
Shared therapeutic areas:
Worked with same sponsors:
Yongchang Zhang, MD
Hunan Cancer Hospital
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D.
National Cancer Institute Naples, Italy
Shared therapeutic areas:
Worked with same sponsors:
James C Yang, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Mattias Rudebeck, PhD MSc BMedSc
Immedica Pharma AB
Shared therapeutic areas:
David R. Spigel, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Francois Benard, MD
BC Cancer
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
All 2 trials loaded